Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077870
Status:
COMPLETED
Last Update Posted:
2009-09-03
First Post:
2004-02-12
Brief Title:
A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Rheumatoid Arthritis |
Keywords:
| Name | View |
|---|---|
| Moderate to severe rheumatoid arthritis | View |